AKRO – akero therapeutics, inc. (US:NASDAQ)
Stock Stats
News
5/6
06:00 pm
akro
Low
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Akero Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – AKRO
5/6
03:24 pm
akro
Low
Akero Therapeutics (AKRO) Slides After Failed Trial, Hit With Class Action Lawsuit – Hagens Berman
5/6
12:06 pm
akro
Medium
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Akero Therapeutics, Inc. (AKRO) Investors
5/6
12:00 pm
akro
Medium
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Akero Therapeutics, Inc. (AKRO) Investors
5/6
05:00 am
akro
High
AKRO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Akero Therapeutics, Inc. Investors Can Join the Class Action Lawsuit!
11/13/2023
07:00 am
akro
2.2%
MISS
8/11/2023
06:00 am
akro
4.5%
BEAT
5/15/2023
07:00 am
akro
3.0%
BEAT
3/5
09:43 am
Maintains
Buy
Buy
UBS
Low
-2.6%
5/2
09:08 pm
akro
Low
Form 4 Akero Therapeutics, Inc. For: May 01 Filed by: Young Jonathan
5/1
07:37 pm
akro
Low
Form 4 Akero Therapeutics, Inc. For: Apr 29 Filed by: Gangloff Scott A.
5/1
07:32 pm
akro
Low
Form 3 Akero Therapeutics, Inc. For: Apr 29 Filed by: Gangloff Scott A.
4/26
04:41 pm
akro
Low
Form ARS Akero Therapeutics, Inc. For: Dec 31
4/26
04:31 pm
akro
Low
Form DEF 14A Akero Therapeutics, Inc. For: Jun 07
Show more
Top News Gainers
3/30 Akero Therapeutics to Announce Results for Week 12 Efficacy Endpoints from NASH Phase 2a BALANCED Study of AKR-001 23.4%
4/9 Akero Therapeutics (NASDAQ: AKRO) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating. 15.2%
3/16 Form 10-K Akero Therapeutics, Inc. For: Dec 31 14.7%
6/19 Form 3 Akero Therapeutics, Inc. For: Jun 19 Filed by: Cheng Andrew 13.4%
4/24 Akero Therapeutics (NASDAQ: AKRO) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $22.00 price target on the stock. 13.1%
6/25 Form 4 Akero Therapeutics, Inc. For: Jun 24 Filed by: Harrison Seth Loring 9.7%
12/19 Form 4 Akero Therapeutics, Inc. For: Dec 17 Filed by: Atlas Venture Fund XI, L.P. 7.6%
6/20 Form 424B4 Akero Therapeutics, Inc. 7.5%
4/13 Akero Therapeutics (NASDAQ: AKRO) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 6.5%
4/7 Akero Therapeutics (NASDAQ: AKRO) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 5.9%
Top News Decliners
3/16 Q4/2019 12/31/2019 EPS -0.550 ZacksConsensus -0.580 ActVsEst 0.030 - Beat -31.4%
1/21 Form 4 Akero Therapeutics, Inc. For: Jan 16 Filed by: Versant Venture Capital VI, L.P. -17.4%
3/18 Akero Therapeutics (NASDAQ: AKRO) had its "buy" rating re-affirmed by analysts at Canaccord Genuity. -14.8%
9/6 Form 8-K Akero Therapeutics, Inc. For: Sep 05 -13.8%
3/6 Form 4 Akero Therapeutics, Inc. For: Mar 04 Filed by: Adelman Robert J -9.7%
12/31 Form 4 Akero Therapeutics, Inc. For: Dec 27 Filed by: Versant Venture Capital VI, L.P. -9.5%
1/2 Form 4 Akero Therapeutics, Inc. For: Dec 31 Filed by: Atlas Venture Fund XI, L.P. -8.7%
3/31 Form 8-K Akero Therapeutics, Inc. For: Mar 31 -7.8%
12/13 Form 4 Akero Therapeutics, Inc. For: Dec 13 Filed by: Rolph Timothy -7.8%
1/14 Form 4 Akero Therapeutics, Inc. For: Jan 13 Filed by: Adelman Robert J -6.0%
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.
Click Here To Register For The Live Online Workshop
In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

20715 N Pima Rd #F108
Scottsdale, AZ 85255
Email: info@newsquantified.com
Copyright Ⓒ News Quanitifed LLC. 1.1.3